| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cbo, COO &CCO | Chief Business Officer And COO | Chief Business Officer
1 company
Hannah Brendan is a Cbo, COO &CCO at Quince Therapeutics, Inc.. Recent SEC Form 4 filings include 7 buys and 0 sells.
Estimated insider holdings value: $342K based on current market prices.